Showing results (221-230 of 281) with videos related to

Sort By:
Pageof 29
Archives of Virology|November 21, 2019
An extensive field study reveals the circulation of new genetic variants of subtype 1a of bovine viral diarrhea virus in UruguayL Maya, M Macías-Rioseco, C Silveira, et al.
Actas Urologicas Espanolas|June 14, 2023
Initial results of the implementation of an ambulatory mini percutaneous nephrolithotomy programA Abella Serra, S Colom Feixas, C Torrecilla Ortiz, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
Allergy|January 26, 2017
Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and ImmunologyA Muraro, R F Lemanske, M Castells, et al.
Actas Urologicas Espanolas|June 5, 2023
Preliminary results of the implementation of robotic radical prostatectomy in a major ambulatory surgery regimenP de Pablos-Rodríguez, J F Suárez Novo, M Castells Esteve, et al.
Allergy|June 3, 2011
Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*Marek L Kowalski, J S Makowska, M Blanca, et al.
Allergy|February 3, 2017
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position PaperM H Shamji, J H Kappen, M Akdis, et al.
Allergy|November 25, 2017
Perspectives in allergen immunotherapy: 2017 and beyondO Pfaar, S Bonini, V Cardona, et al.
Allergy|March 19, 2016
In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paperC Mayorga, G Celik, P Rouzaire, et al.
Pageof 29